Literature DB >> 14718940

Genetic information and testing in insurance and employment: technical, social and ethical issues.

Béatrice Godard1, Sandy Raeburn, Marcus Pembrey, Martin Bobrow, Peter Farndon, Ségolène Aymé.   

Abstract

The present paper examines the professional and scientific views on the social, ethical and legal issues that impact on genetic information and testing in insurance and employment in Europe. For this purpose, many aspects have been considered, such as the concerns of medical geneticists, of the insurers and employers, of the public, as well as the regulatory frameworks and unresolved issues. The method used was primarily the review of the technical, social, economical and ethical aspects of advances in genetics and the concerns of parties who are involved, that is, the insurers, the employers and the public. The existing guidelines and legislation on this topic were also reported. Then, the method was to examine the issues debated by these parties in Europe, as well as by 47 experts from 14 European countries invited to an international workshop organized by the European Society of Human Genetics Public and Professional Policy Committee in Manchester, UK, 25-27 February 2000. The result of this was that the most important issues raised by genetic information and testing in insurance and employment in Europe include a need for clear definitions of terms used in genetics, declaring the grounds on which genetic information is or is not used, and promoting confidence between the public and the insurance industry. There is currently very little use of genetic information in relation to employment, but the situation should be kept under review.

Entities:  

Keywords:  Genetics and Reproduction; Legal Approach

Mesh:

Year:  2003        PMID: 14718940     DOI: 10.1038/sj.ejhg.5201117

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

Review 1.  Just a family medical history?

Authors:  Dagmar Schmitz; Urban Wiesing
Journal:  BMJ       Date:  2006-02-04

2.  Should genetic information be disclosed to insurers? No.

Authors:  Richard Ashcroft
Journal:  BMJ       Date:  2007-06-09

3.  Genetic information, insurance and a pluralistic approach to justice.

Authors:  Jonathan Pugh
Journal:  J Med Ethics       Date:  2021-04-15       Impact factor: 2.903

4.  The wide variation of definitions of genetic testing in international recommendations, guidelines and reports.

Authors:  Jorge Sequeiros; Milena Paneque; Bárbara Guimarães; Elina Rantanen; Poupak Javaher; Irma Nippert; Jörg Schmidtke; Helena Kääriäainen; Ulf Kristoffersson; Jean-Jacques Cassiman
Journal:  J Community Genet       Date:  2012-02-25

5.  Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study.

Authors:  François Eisinger; Roxane Fabre; Christine Lasset; Dominique Stoppa-Lyonnet; Claire Julian-Reynier; Catherine Nogues
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

6.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

Review 7.  What is the role of genetic testing in movement disorders practice?

Authors:  Susanne A Schneider; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

8.  Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality.

Authors:  Allison Meisner; Prosenjit Kundu; Yan Dora Zhang; Lauren V Lan; Sungwon Kim; Disha Ghandwani; Parichoy Pal Choudhury; Sonja I Berndt; Neal D Freedman; Montserrat Garcia-Closas; Nilanjan Chatterjee
Journal:  Am J Hum Genet       Date:  2020-08-05       Impact factor: 11.025

Review 9.  The law of incidental findings in human subjects research: establishing researchers' duties.

Authors:  Susan M Wolf; Jordan Paradise; Charlisse Caga-anan
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

10.  Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers.

Authors:  Imke Christiaans; Tjitske M Kok; Irene M van Langen; Erwin Birnie; Gouke J Bonsel; Arthur A M Wilde; Ellen M A Smets
Journal:  Eur J Hum Genet       Date:  2009-08-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.